Vireo Growth (VREOF) Interest & Investment Income (2025)

Vireo Growth (VREOF) posted Interest & Investment Income of $5.6 million for Q4 2025, up 33183.43% sequentially from $16707.0 in Q2 2025.

Vireo Growth (VREOF) Interest & Investment Income (2025) Analysis & Trends

Vireo Growth has reported Interest & Investment Income for 1 years, with the latest figure at $5.6 million in Q4 2025.

Quarterly Interest & Investment Income changed N/A year-over-year to $5.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.7 million (changed N/A YoY) and the FY2025 annual result came in at $5.7 million, up 6252.22% from the prior year.
Interest & Investment Income improved to $5.6 million in Q4 2025 per VREOF's latest filing, from $16707.0 in the prior quarter.
Over five years, Interest & Investment Income peaked at $5.6 million in Q4 2025 and troughed at $16707.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Haleon	43.76 Bn	42.80 Bn	-	-
2	Teva Pharmaceutical Industries	43.05 Bn	39.39 Bn	2.15 Bn	-
3	Zoetis	31.51 Bn	29.84 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.70 Bn	22.90 Bn	5.10 Bn	154.39 Mn
5	United Therapeutics	22.27 Bn	19.61 Bn	683.80 Mn	31.50 Mn
6	Viatris	18.83 Bn	17.95 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.65 Bn	15.26 Bn	935.80 Mn	12.40 Mn
8	Elanco Animal Health	12.06 Bn	11.53 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-	-
10	Vireo Growth	493.25 Mn	350.95 Mn	95.30 Mn	700,000.00

Download Data